$ILMN 4/A SEC Filings

Filed On	Filing
29 May 2026	Form 4/A: Meister Keith A., Director Holds 3,500,048 shares of Common Stock
16 Nov 2022	Form 4/A: Hoyt Aimee L, SVP, Chief People Officer Sold 1,045 shares ($234K)
13 Dec 2018	Form 4/A: Flatley Jay T, Director Gave up 4,632 shares to cover exercise price or tax ($1.52M)
16 Jun 2017	Form 4/A: Huber Jeff, Director Received 6,059 shares as a grant or award
16 Jun 2017	Form 4/A: Arnold Frances, Director Received 6,156 shares as a grant or award
11 Jul 2016	Form 4/A: deSouza Francis A, Director Received 2,705 shares as a grant or award · Granted 8,113 Performance Shares
04 Jan 2016	Form 4/A: Huber Jeff, Director Received 66 shares as a grant or award ($13.6K)
05 Oct 2015	Form 4/A: Huber Jeff, Director Received 68 shares as a grant or award ($13.7K)
05 Oct 2015	Form 4/A: Huber Jeff, Director Received 70 shares as a grant or award ($13.5K)
12 Aug 2015	Form 4/A: Epstein Robert S, Director Received 2,000 shares by exercise or conversion ($102K) · Sold 2,000 shares ($428K)
29 Jul 2015	Form 4/A: Dadswell Charles, Sr VP & General Counsel Sold 160 shares ($34.5K)
21 Jul 2015	Form 4/A: Ronaghi Mostafa, Sr VP & CTO Sold 1,000 shares ($225K) · Sold 1,000 shares ($232K)
10 Jul 2015	Form 4/A: Flatley Jay T, Chief Executive Officer Received 25,000 shares by exercise or conversion ($816K) · Sold 25,000 shares ($5.51M)
26 Aug 2014	Form 4/A: Bowman A Blaine, Director Received 5,000 shares by exercise or conversion ($73.4K) · Sold 5,000 shares ($815K)
10 Jan 2014	Form 4/A: Bouchard Michel, Chief Accounting Officer Acquired 788 Non-Qualified Stock Option (right to buy) (Other Transaction)
30 Jan 2013	Form 4/A: Lewis Mark L, SVP & GM Molecular Biology Holds 41,885 shares of Common Stock
18 Jul 2011	Form 4/A: Flatley Jay T, Director Received 25,000 shares by exercise or conversion ($108K) · Sold 25,000 shares ($1.84M)
29 Jan 2010	Form 4/A: Heath Gregory, Sr VP & General Manager Received 6,667 shares as a grant or award · Granted 60,000 Non-Qualified Stock Option (right to buy) · Gave up 458 shares to cover exercise price or tax ($16.6K)
28 Oct 2009	Form 4/A: Whitfield Roy A, Director Exercised 3,000 Non-Qualified Stock Option (right to buy)
19 Oct 2009	Form 4/A: Cabou Christian, Senior VP, General Counsel Exercised 9,000 Non-Qualified Option (right to buy)

Comments